©The Author(s) 2025.
World J Psychiatry. Nov 19, 2025; 15(11): 108688
Published online Nov 19, 2025. doi: 10.5498/wjp.v15.i11.108688
Published online Nov 19, 2025. doi: 10.5498/wjp.v15.i11.108688
Table 2 Clinicopathological data of the two patient groups, n (%)
| Factors | n | PSD group (n = 96) | NPSD group (n = 104) | χ2 | P value |
| Number of comorbid conditions | 11.836 | 0.003 | |||
| 0 | 35 | 23 (23.96) | 12 (11.54) | ||
| 1 | 108 | 40 (41.67) | 68 (65.38) | ||
| ≥ 2 | 57 | 33 (34.38) | 24 (23.08) | ||
| Severity of neurological impairment | 8.144 | 0.017 | |||
| Mild | 40 | 12 (12.50) | 28 (26.92) | ||
| Moderate | 123 | 61 (66.67) | 62 (59.62) | ||
| Severe | 37 | 23 (23.96) | 14 (13.46) | ||
| Lesion location | 0.131 | 0.936 | |||
| Frontal lobe | 90 | 44 (45.83) | 46 (44.23) | ||
| Temporal lobe | 65 | 30 (31.25) | 35 (33.65) | ||
| Basal ganglia | 45 | 22 (22.92) | 23 (22.12) | ||
| Number of lesions | 5.998 | 0.014 | |||
| Single | 78 | 29 (30.21) | 49 (47.12) | ||
| Multiple | 122 | 67 (69.79) | 55 (52.88) |
- Citation: Han Z, Zhang DD, Li NN. Influencing factors and construction of a nomogram for post-stroke depression in patients with chronic stroke. World J Psychiatry 2025; 15(11): 108688
- URL: https://www.wjgnet.com/2220-3206/full/v15/i11/108688.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i11.108688